Literature DB >> 2213511

A study of HTLV-I and its associated risk factors in Trinidad and Tobago.

W A Blattner1, C Saxinger, D Riedel, B Hull, G Taylor, F Cleghorn, R Gallo, B Blumberg, C Bartholomew.   

Abstract

Seroprevalence of human T-lymphotropic virus type 1 (HTLV-I) among a sample of persons selected from a government register of businesses in Trinidad was 3.2% in 1,025 persons of African descent compared to 0.2% among 487 persons of Asian descent and 0% among 46 persons of European-descent. In Tobago, from a coastal village, among persons of African ancestry ascertained as part of a cardiovascular survey, the rate was 11.4%, which was significantly higher when corrected for age and race than the rate in Trinidad. The seroprevalence rate of antibodies to hepatitis A and B was also significantly elevated in Tobago compared to Trinidad. HTLV-I seroprevalence rates were higher in females than males while hepatitis A and B rates were not significantly different in the two sexes. For males, age was a significant determinant of HTLV-I seropositivity, while for females, age, markers of poor sanitation, and hepatitis B were each independently linked to HTLV-I seropositivity. The frequent occurrence of multiple infectious exposures in persons of lower socioeconomic circumstances in this tropical environment may result in immune activation that heightens susceptibility to HTLV-I infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213511

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  7 in total

1.  Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain.

Authors:  Ana Treviño; Luiz Carlos Alcantara; Rafael Benito; Estrella Caballero; Antonio Aguilera; José Manuel Ramos; Carmen de Mendoza; Carmen Rodríguez; Juan García; Manuel Rodríguez-Iglesias; Raúl Ortiz de Lejarazu; Lourdes Roc; Patricia Parra; José Eiros; Jorge del Romero; Vincent Soriano
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-09       Impact factor: 2.205

2.  Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies.

Authors:  R Mahieux; F Ibrahim; P Mauclere; V Herve; P Michel; F Tekaia; C Chappey; B Garin; E Van Der Ryst; B Guillemain; E Ledru; E Delaporte; G de The; A Gessain
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  High seroprevalence of human T-cell lymphotropic virus type 1 in blood donors in Guyana and molecular and phylogenetic analysis of new strains in the Guyana shelf (Guyana, Suriname, and French Guiana).

Authors:  Jean-François Pouliquen; Lynette Hardy; Anne Lavergne; Eric Kafiludine; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

Review 4.  Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.

Authors:  E L Murphy
Journal:  Transfus Clin Biol       Date:  2016-01-05       Impact factor: 1.406

5.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

6.  Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran.

Authors:  M R Hedayati-Moghaddam; F Fathimoghadam; I Eftekharzadeh Mashhadi; L Soghandi; H R Bidkhori
Journal:  Iran Red Crescent Med J       Date:  2011-06-01       Impact factor: 0.611

7.  The Prevalence of Human T-Cell lymphotropic Virus Type 1 in Pregnant Women and Their Newborns.

Authors:  A Hamedi; F Akhlaghi; Z Meshkat; M Sezavar; H Nomani; M Meshkat
Journal:  ISRN Obstet Gynecol       Date:  2012-11-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.